Chujo, S.; Matsubara, H.; Mase, Y.; Kato, K.; Kondo, M.
Recurrence Rate during 5-Year Period after Suspension of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration. J. Clin. Med. 2024, 13, 4317.
https://doi.org/10.3390/jcm13154317
AMA Style
Chujo S, Matsubara H, Mase Y, Kato K, Kondo M.
Recurrence Rate during 5-Year Period after Suspension of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration. Journal of Clinical Medicine. 2024; 13(15):4317.
https://doi.org/10.3390/jcm13154317
Chicago/Turabian Style
Chujo, Shinichiro, Hisashi Matsubara, Yoko Mase, Kumiko Kato, and Mineo Kondo.
2024. "Recurrence Rate during 5-Year Period after Suspension of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration" Journal of Clinical Medicine 13, no. 15: 4317.
https://doi.org/10.3390/jcm13154317
APA Style
Chujo, S., Matsubara, H., Mase, Y., Kato, K., & Kondo, M.
(2024). Recurrence Rate during 5-Year Period after Suspension of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration. Journal of Clinical Medicine, 13(15), 4317.
https://doi.org/10.3390/jcm13154317